A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

Information and advice if you have had a third or fourth degree perineal tear - patient information

Description
This factsheet explains what a third and fourth degree perineal tear is, and what the treatment and aftercare for this type
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Information-and-advice-if-you-have-had-a-third-or-fourth-degree-perineal-tear-1050-PIL.pdf

Practice reading passages - patient information

Description
This factsheet contains some passages that help you control your breathing pattern when talking.
Url
/Media/UHS-website-2019/Patientinformation/Respiratory/Practice-reading-passages-755-PIL.pdf

DART study privacy notice

Description
Your role in improving the diagnosis of lung disease Information Sheet and Privacy Notice Oxford University is leading a project to
Url
/Media/UHS-website-2019/Docs/Services/Blood-heart-and-circulation/DART-study-privacy-notice.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carboplatin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Carboplatin-Vinorelbine Oral

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-VINORELBINE (Oral) Regimen  NSCLC – Carboplatin (AUC6)-Vinorelbine (Oral) Indication  First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-Oral.pdf

Your stay at the major trauma centre - patient information

Description
This factsheet gives you useful information about your stay at the major trauma centre.
Url
/Media/UHS-website-2019/Patientinformation/Major-Trauma-Centre/Your-stay-at-the-major-trauma-centre-3125-PIL.pdf

Neratinib

Description
Chemotherapy Protocol Breast Cancer NERATINIB Regimen • Breast Cancer – Neratinib Indication • Neratinib for extended adjuvant therapy for hormone receptor positive HER2overexpressed early
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Neratinib.pdf

Vismodegib

Description
Chemotherapy Protocol BASAL CELL CARCINOMA (BCC) VISMODEGIB Regimen  BCC - Vismodegib Indication  The patient either has; a. Gorlin Syndrome with non-locally
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Vismodegib.pdf

Total body irradiation (TBI) - patient information

Description
This factsheet explains what to expect at your TBI treatment appointments.
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Total-body-irradiation-TBI-1332-PIL.pdf

Docetaxel-Nintedanib v1

Description
Chemotherapy Protocol NSCLC CANCER DOCETAXEL-NINTEDANIB Regimen NSCLC – Docetaxel-Nintedanib Indication Advanced or metastatic NSCLC of adenocarcinoma origin that has progressed
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxel-Nintedanib-v1.pdf
311 to 320 of 1000
Previous … 30 31 32 33 34 … Next